Anixa Biosciences, Inc. (ANIX)
USD 2.64
(-0.75%)
USD 2.64
(-0.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.2 Million | -6.49 Million | -4.93 Million | -6.17 Million | -4.74 Million | -4.27 Million |
| Net Income | -9.93 Million | -13.77 Million | -13.12 Million | -10.09 Million | -11.81 Million | -14.24 Million |
| Depreciation & Amortization | 46 Thousand | 42 Thousand | 59.86 Thousand | 90.15 Thousand | 466.3 Thousand | 343.73 Thousand |
| Deferred income taxes | - | - | - | - | - | 647.63 Thousand |
| Stock-based compensation | 4.42 Million | 6 Million | 7.5 Million | 3.92 Million | 5.71 Million | 8.89 Million |
| Change in working capital | -1.06 Million | 485 Thousand | 78.54 Thousand | -459 Thousand | 478.42 Thousand | 67.7 Thousand |
| Other non-cash items | 92 Thousand | 752 Thousand | -5447.00 | 148.08 Thousand | 418.75 Thousand | 15 Thousand |
| Investing Cash Flow | -5.6 Million | -10.72 Million | -3.91 Million | -305.79 Thousand | -525.45 Thousand | 1.46 Million |
| Investments in PPE | - | - | - | -15.79 Thousand | -175.45 Thousand | -38.4 Thousand |
| Acquisitions | - | - | 6473.00 | 5.01 Million | 3.85 Million | 4.25 Million |
| Investment purchases | -44.41 Million | -22.48 Million | -16.49 Million | -5.01 Million | -3.85 Million | -4.25 Million |
| Sales/Maturities of investments | 38.8 Million | 11.75 Million | 12.53 Million | 4.72 Million | 3.5 Million | 5.75 Million |
| Other Investing Activities | -5.6 Million | -10.72 Million | 35.44 Thousand | -5.01 Million | -3.85 Million | -4.25 Million |
| Financing Cash Flow | 366 Thousand | 452 Thousand | 31.56 Million | 9.4 Million | 5.7 Million | 2.52 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 92 Thousand | 97 Thousand | 31.12 Million | 9.26 Million | 5.52 Million | 2.47 Million |
| Other Financing Activities | 274 Thousand | 355 Thousand | 440.22 Thousand | 140.72 Thousand | 175.19 Thousand | 58.13 Thousand |
| Accounts receivables | -224 Thousand | -29 Thousand | - | 64.29 Thousand | 271.7 Thousand | -258.99 Thousand |
| Accounts payables | -59 Thousand | 129 Thousand | -96.17 Thousand | -353.44 Thousand | 3805.00 | 101.68 Thousand |
| Inventory | 224 Thousand | 29 Thousand | - | -64.29 Thousand | -271.7 Thousand | - |
| Other working capital | -1 Million | 356 Thousand | 174.71 Thousand | -105.56 Thousand | 474.61 Thousand | -33.98 Thousand |
| Cash at beginning of period | 12.36 Million | 29.12 Million | 6.41 Million | 3.49 Million | 3.05 Million | 3.33 Million |
| Cash at end of period | 915 Thousand | 12.36 Million | 29.12 Million | 6.41 Million | 3.49 Million | 3.05 Million |
| Capital Expenditure | - | - | - | -15.79 Thousand | -175.45 Thousand | -38.4 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -11.44 Million | -16.76 Million | 22.71 Million | 2.92 Million | 435.73 Thousand | -283.48 Thousand |
| Free Cash Flow | -6.2 Million | -6.49 Million | -4.93 Million | -6.19 Million | -4.91 Million | -4.31 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.27 Million | -3.13 Million | -3.25 Million | -9.93 Million | -2.72 Million | -2.54 Million |
| Depreciation & Amortization | 3000.00 | 12 Thousand | 13 Thousand | 46 Thousand | 12 Thousand | 11 Thousand |
| Deferred income taxes | - | - | -37 Thousand | - | - | - |
| Stock-based compensation | 1.09 Million | 1.23 Million | 1.1 Million | 4.42 Million | 1.15 Million | 1.15 Million |
| Change in working capital | -607 Thousand | 452 Thousand | -292 Thousand | -1.06 Million | -488 Thousand | -125 Thousand |
| Other non-cash items | 1.34 Million | 1.21 Million | 154 Thousand | 92 Thousand | 25 Thousand | 17 Thousand |
| Investing Cash Flow | 2.72 Million | 556 Thousand | 129 Thousand | -5.6 Million | -593 Thousand | -980 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -12.56 Million | -14.71 Million | -20.02 Million | -44.41 Million | -16.9 Million | -10.09 Million |
| Sales/Maturities of investments | 15.29 Million | 15.27 Million | 20.14 Million | 38.8 Million | 16.31 Million | 9.11 Million |
| Other Investing Activities | 2.72 Million | - | 129 Thousand | -5.6 Million | -593 Thousand | -980 Thousand |
| Financing Cash Flow | 149 Thousand | 897 Thousand | 2.26 Million | 366 Thousand | 279 Thousand | 3000.00 |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 149 Thousand | 897 Thousand | 2.26 Million | 92 Thousand | 279 Thousand | 3000.00 |
| Other Financing Activities | 149 Thousand | - | 2.16 Million | 274 Thousand | 296 Thousand | 3000.00 |
| Accounts receivables | -192 Thousand | 173 Thousand | -121 Thousand | -224 Thousand | 64 Thousand | -79 Thousand |
| Accounts payables | 87 Thousand | -149 Thousand | 158 Thousand | -59 Thousand | 112 Thousand | -102 Thousand |
| Inventory | - | - | - | 224 Thousand | -64 Thousand | 79 Thousand |
| Other working capital | -502 Thousand | 428 Thousand | -329 Thousand | -1 Million | -600 Thousand | -23 Thousand |
| Cash at beginning of period | 995 Thousand | 998 Thousand | 915 Thousand | 12.36 Million | 3.19 Million | 5.62 Million |
| Cash at end of period | 1.22 Million | 995 Thousand | 998 Thousand | 915 Thousand | 915 Thousand | 3.19 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | -3.63 Million | 1.2 Million |
| Net cash flow / Change in cash | 230 Thousand | -3000.00 | 83 Thousand | -11.44 Million | -2.28 Million | -2.42 Million |
| Free Cash Flow | -2.64 Million | -1.45 Million | -2.3 Million | -6.2 Million | -1.96 Million | -1.44 Million |
GBNY
SEACOAST
NTCT
1443
LHA
FMCKN